Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study
NCT ID: NCT01465620
Last Updated: 2018-08-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
8 participants
INTERVENTIONAL
2011-11-30
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiac Autonomic Neuropathy in Patients With Metabolic Syndrome
NCT00907127
Exercise-facilitated Neurorehabilitation in Diabetic Neuropathy
NCT00955201
Graded Exposure in Patients With Painful Diabetic Neuropathy
NCT03066570
Evaluating the Effect of Diabetes Control Through Intensive Lifestyle Modifications on Diabetic Peripheral Neuropathy
NCT01565317
Exercise and Nerve Function in Diabetes
NCT00970060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. the effect of physical training and diet education on neuropathic symptoms and neurophysiological parameters
2. the best coaching modality of education.
This will be a prospective single blind study (blinded evaluator). Patients will be randomly assigned in two groups. The first group will have a one-day therapeutic education program followed by a 5-minutes phone call every week for 3 months. The second group will have the same one-day therapeutic education program that will be followed by an unique one-hour phone call. During the one-day therapeutic education program and the phone calls, hygienic rules (ie physical activities) and dietetic regimen advices will be given to patients. Evaluation will be done at 3 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Coaching
active hygienic-dietetic coaching
hygienic-dietetic measures
Therapeutic education about hygienic-dietetic measures followed by a 5 minutes phone call per week during 3 months
control
reference hygienic-dietetic recommendations
hygienic-dietetic measures
Therapeutic education about hygienic-dietetic measures followed by only one phone call
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hygienic-dietetic measures
Therapeutic education about hygienic-dietetic measures followed by a 5 minutes phone call per week during 3 months
hygienic-dietetic measures
Therapeutic education about hygienic-dietetic measures followed by only one phone call
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Metabolic disorder: Glucose disorder (diabetes mellitus or glucose intolerance) or metabolic syndrome
* Clinical signs for less than 2 years
* No therapeutic modification in the last 3 months
* Possibility to delay any drug modification during 3 months
Exclusion Criteria
* Serious diabetic complication
* Renal failure (creatinine clearance\<60ml/min)
* Sensory neuronopathy
* Contra-indication to physical activity
* Type 1 diabetes mellitus
* No written consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Henri Mondor University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sophie Ng Wing Tin
Investigator, clinical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alain Créange, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Henri Mondor University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Henri Mondor
Créteil, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.